Back
ESC2025 Premium Access

Native QRS duration and outcomes in heart failure with mildly reduced ejection fraction: results from a large-scaled registry

Session: Novel biomarkers for risk assessment of your patient with heart failure
Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
Speaker: Doctor T. Schupp (Mannheim, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tobias Schupp

University Medical Centre of Mannheim, Mannheim (Germany)
0 follower

7 more presentations in this session

Association of blood biomarkers with cardiovascular and kidney adverse outcomes in people with heart failure with preserved ejection fraction

Speaker: Assistant Professor B. Roehm (Dallas, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Thyroid function and outcomes in heart failure with mildly reduced ejection fraction: insights from a large, retrospective registry

Speaker: Doctor M. Abumayyaleh (Mannheim, DE)

Access
Abstract
Slides
Like
Thumbnail

Prevalence and prognostic impact of coronary artery disease in heart failure with preserved ejection fraction

Speaker: Doctor M. Shiba (Osaka, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Clinical determinants of MYDGF in a heart failure population - results from the Emperor biomarker program

Speaker: Doctor M. Panova-Noeva (Ingelheim am Rhein, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

One-year prognosis according to BMI among heart failure patients with preserved and mildly reduced ejection fraction in Polish cohort - insights from HF-POL registry

Speaker: Doctor E. Kazimierczyk (Bialystok, PL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Novel biomarkers for risk assessment of your patient with heart failure

Speakers: Doctor T. Schupp, Assistant Professor B. Roehm, Doctor M. Abumayyaleh, Doctor M. Shiba, Doctor M. Panova-Noeva...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources